Home > Financial Ratios > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
EV/Core EBITDA

    Back to All Ratios
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.5119.2419.0315.1011.32

What is the latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES is 26.51 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202426.51
Mar202319.24
Mar202219.03
Mar202115.10
Mar202011.32

How is EV/Core EBITDA of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years EV/Core EBITDA % Change
Mar2024 26.51
37.79
Mar2023 19.24
1.10
Mar2022 19.03
26.03
Mar2021 15.1
33.39
Mar2020 11.32 -

Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES


Compare EV/Core EBITDA ratio of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹399,243.5 Cr -1.3% -3.3% 8.3% Stock Analytics
DIVIS LABORATORIES ₹174,940.0 Cr -1.5% 0.8% 42.3% Stock Analytics
CIPLA ₹121,197.0 Cr -1.7% 2.3% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,618.0 Cr -1.6% 8.4% 10.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,250.0 Cr -3.3% -1.4% 9.8% Stock Analytics
MANKIND PHARMA ₹94,475.7 Cr -3.3% -6.1% 3.4% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-1.3%

-3.3%

8.3%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses